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doi:10.1016/j.jmii.2011.09.016Corynebacterium striatum (C striatum) has been considered a contaminant of blood culture in
past decades. Here we report the case of a patient with acute deterioration of chronic renal
failure. She received hemodialysis and died from C striatum bacteremia. By using a randomly
amplified polymorphic DNA (RAPD) method, we found that an association existed between C
striatum from the bloodstream and that from the central venous catheter. We suggest that
C striatum could be a pathogen of bloodstream infection in patients with such a catheter in
place.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Corynebacteria are Gram-positive, catalase-positive,
aerobic or facultative anaerobic, generally non-motile
rods. The genus contains Corynebacterium diphtheriae
and non-diphtherial corynebacteria, collectively referred
to as diphtheroids. Non-diphtherial corynebacteria (CInfectious Disease, Depart-
ng Hospital, Taipei Medical
v.tw (W.-S. Lee).
an Society of Microbiology. Publstriatum, C amycolatum, C minutissimum, C xerosis and
C freneyi) were originally thought to be contaminants. They
have increasingly been reported as emergent opportunistic
pathogens in immunocompromised hosts, such a patients
with end-stage renal disease, hematologic malignancies or
with critical illness.1 Recognition of infections caused by
coryneform bacteria is highly dependent on the level
of alert and attentiveness of clinicians.
C striatum has previously been considered a saprophyte
on skin and nasal mucosa, but it has been reported to be
responsible for various type of infections, such as
pneumonia, cerebro-spinal fluid infection, endocarditis,
osteomyelitis of the diabetic foot, peritonitis in patientsished by Elsevier Taiwan LLC. All rights reserved.
256 F.-L. Chen et al.with peritoneal dialysis, septic arthritis and septicemia.
Outbreaks of C striatum infections were also reported in
long-stay hospitalized patients with underlying disease.3e7
Here we present the case of a patient with acute dete-
rioration of chronic renal failure who developed C striatum
in bacteremia. Using randomly amplified polymorphic DNA
(RAPD) methods, we found that the same pathogens existed
in the bloodstream and on the central venous catheter. The
patient died from septic shock and multiple-organ failure
due to delayed treatment.Patient and methods
An 83-year-old woman was brought to our emergency
department on December 19, 2008 due to loss of
consciousness and cardiac arrest in the early morning. Her
vital signs were recovered after cardiopulmonary resusci-
tation and then she was immediately admitted to the
intensive care unit (ICU). Her underlying diseases were
chronic renal insufficiency and hypertensive cardiovascular
disease. Her white blood cell count was 16,080 cells/mL,
her platelet count was 195,000 cells/mL and her hemoglobin
level was 8.1 gm/dL. The patient’s C-reactive protein level
was 16.96 mg/dL. Her blood urea nitrogen level was
105 mg/dL and her creatinine level was 5.79 mg/dL. Her
aspartate aminotransferase was 114 U/L, her alanine
aminotransferase was 76 U/L, and her total bilirubin was
0.75 mg/dL. She received a central venous catheter in the
right internal jugular vein to ensure venous access and was
monitored for central venous pressure.
Due to her chronic renal failure with acute deteriora-
tion, the patient was given hemodialysis after hospitaliza-
tion. A temporary double-lumen catheter was placed in the
right femoral vein for hemodialysis on day 2 after admis-
sion. On account of the her uremic status and the fact that
she was being considered for long-standing hemodialysis,
the site of vascular access was changed to the left subcla-
vian vein and substituted by Permcath dual-lumen on day
11 after admission.
On admission, the patient received piperacillin/tazo-
bactam (2.25 g by intravenous injection every 6 hours),
levofloxacin (500 mg intravenous injection every other day)
and dopamine (10 meq/Kg/hour) for aspiration pneumonia
and shock status. The findings from initial cultures yielded
methicillin-sensitive Staphylococcus aureus from one of
three sets of blood cultures and one set of sputum culture.
The results of sensitivity testing this strain showed that it
was sensitive to levofloxacin.
She received piperacillin/tazobactam and levofloxacin
for the 14 days in which she stayed in the ICU. Due to
ventilator dependence, the patient was transferred to the
respiratory care center for further management on day 14
after admission.
The patient was put on fluconazole on day 17 after
admission for a urinary tract infection with Candida
albicans.
She was successfully weaned from the mechanical
ventilator on day 18 after admission. Unfortunately, she
developed fever and respiratory distress after the removal
of the endotracheal tube and she was given bi-level positive
airway pressure ventilation because the families did notwant her to receive endotracheal ventilation. Cefpirome
(1 g intravenous injection every 12 hours) was administered
for sputum culture revealing Enterobacter cloacae.
The patient’s complete blood count on day 25 after
admission showed significant leukocytosis. The central
venous catheter in the right internal jugular vein was
removed due to fever and the catheter tip was sent for
a semiquantitative culture on day 26. Two sets of blood
culture (each set including aerobic and anaerobic samples),
including one set drawn from the right internal jugular
venous catheter at the same time, contained C striatum. At
first, C striatum was considered to be contaminant and we
did not prescribe any antibiotics. Her fever persisted,
however, and the hemodynamic condition became
unstable, especially during hemodialysis.
The results of repeated blood culture on days 30 and 34
still yielded C striatum. The C striatum susceptibility test
showed that the strain was sensitive to vancomycin, line-
zolid, tigecycline and amoxicillin/clavulanate but resistant
to ciprofloxacin, erythromycin, rifampin, tetracyclines,
gentamicin and penicillin. The patient received amoxi-
cillin/clavulanic acid (1.8 g intravenous injection every 8
hours) and vancomycin (1 g loading and 500 mg intravenous
injection every 3 days) on day 30. Unfortunately, she star-
ted to go into septic shock and multiple-organ failure on
day 35, and the patient expired at midnight.
From the patient’s specimens, we identified six strains
of C striatum from blood culture (aerobic and anaerobic)
and three strains from the central venous catheter. The
RAPD patterns of these nine isolates and two
epidemiologically-unrelated isolates from another hospital
were determined by arbitrarily-primed PCR using four
random primers:
 A (50-AGCAGCGCCTCA-30);
 S (50-TCACGATGCA-30);
 M13 (50-GTTTTCCCAGTCACGAC-30); and
 OPB17 (50-AGGGAACGAG-30).
We found that the RAPD patterns from the nine isolates
from the patient (strains 1e6 from blood, strains 7e9 from
central venous catheter) were identical to each other
(strains 19) and were different to those from the other
hospital (strains 10 and11), see Fig. 1. Based on those
observations, we suspect that the strains of C striatum
found in the bloodstream match those from the central
venous catheter. We therefore considered that the central
venous catheter was the route of bloodstream infection in
this patient.Discussion
To our knowledge, this is the first report of a serial blood
culture positive for C striatum, having the same genotype
with central venous catheter tip strains. Although C stria-
tum is infrequently isolated from blood culture, its degree
of pathogenicity and the differentiation of colonization
from pathogen-causing infections is still difficult to delin-
eate. Septicemia with C striatum is a rare event and the
route of transmission was first proven by molecular confir-
mation of entry through the skin in 2003 by Martin et al.5
Figure 1. Molecular analysis of C. striatum strains isolated from blood and central venous catheter using the randomly amplified
polymorphic DNA method. Key: lanes 16 Z isolates from peripheral blood culture, lanes 79 Z isolates from catheter tip and
intra-catheter blood culture and lanes 1011 Z isolates from another hospital (for comparison). Prime A and Prime S were the
specific gene of C. striatum.
Corynebacterium striatum bacteraemia 257The victim was a 69-year-old male with ischemic heart
disease, refractory anemia and thyroid cancer who was
found to be suffering from a blood-stream infection initi-
ated by a known skin focus.5
Opportunistic corynebacteria infections were thought to
originate endogenously, but in recent years the possibility
of patient-to-patient transmission in ICU has been
described in two studies using restriction fragment-length
polymorphism analysis.9e12 Outbreaks caused by multidrug-
resistant C striatum have been reported in patients hospi-
talized for a long time who have had indwelling devices,
prolonged exposure to broad-spectrum antibiotics and
immunosuppression.9,10,13
Although most reported C striatum isolates are suscep-
tible to a wide range of antibiotics,2,8,14 it has been sug-
gested that the selective pressure exerted by previous
antimicrobial treatment has contributed to the overgrowth
of C striatum, leading to it becoming a secondary colonizer
in immunocompromised hosts.9 In general, C striatum is
resistant to penicillin but is susceptible to other b-lactams
and vancomycin. In a previous report, vancomycin was
recommended as an empirical therapy for serious infections
caused by corynebacteria.15 The optimal antimicrobial
therapy for C striatum infections is, however, controver-
sial. In vitro susceptibility tests of tigecycline and linezolid
show that they are active against coryneform bacteria.16,17
At present, there is no ‘gold standard’ or guideline for the
management of corynebacteria found in in vitro sensitivity
tests. In light of the emergence of multidrug resistance and
its involvement in nosocomial infections, appropriate
interpretive criteria are needed for corynebacteria.
In conclusion, we cannot assume that C striatum culti-
vated from blood culture is only a contaminant. We need
to suspect the possibility of endocarditis in high-risk
patients, especially in those with history of exposure to
broad-spectrum antibiotics, immunosuppression or with
a central venous catheter in place. The findings of this casereport highlight that we need to be aware that C striatum is
an emerging nosocomial pathogen, especially in critically ill
patients with indwelling devices.Conflict of interest
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